Camilla Hammerum | Vice President, Global Patient Safety, Neuroscience Therapeutic Area Head
Ipsen

Camilla Hammerum, Vice President, Global Patient Safety, Neuroscience Therapeutic Area Head, Ipsen

Camilla Hammerum is VP and Therapeutic Area Lead for Neuroscience in Global Patient Safety (GPS) at Ipsen based in the UK. For 3½ years, she has led the Neuroscience Team within GPS, to ensure effective, proactive medical safety strategies and continuous management of the safety profile for all development compounds and marketed products within the TA, so that safety considerations reliably inform project decision-making.

Prior to joining Ipsen, Camilla worked for almost 10 years at Lundbeck. In her last post as Head of Medical Safety, Psychiatry in Global Pharmacovigilance. Camilla is a member of the Faculty of Pharmaceutical Medicine in London and before joining the industry, she practised as a GP.

Appearances:



World Drug Safety Congress Americas 2022 Day 1 @ 13:40

ROUNDTABLE 13: Pharmacovigilance in clinical trials

last published: 01/Oct/22 14:05 GMT

back to speakers

Get Involved At Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Semen Sen
Semen.sen@terrapinn.com
t/ +1 646 619 1793

 

 

To Speak


Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

Marketing & Press Opportunities


Taylor Post
taylor.post@terrapinn.com
t/ +1 646 619 1785